- Home
- HEQ vs HBIO Comparison
HEQ vs HBIO Comparison
Compare HEQ & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEQ
- HBIO
- Stock Information
- Founded
- HEQ 2011
- HBIO 1901
- Country
- HEQ United States
- HBIO United States
- Employees
- HEQ N/A
- HBIO N/A
- Industry
- HEQ Investment Managers
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- HEQ Finance
- HBIO Industrials
- Exchange
- HEQ Nasdaq
- HBIO Nasdaq
- Market Cap
- HEQ 130.1M
- HBIO 106.4M
- IPO Year
- HEQ N/A
- HBIO 2000
- Fundamental
- Price
- HEQ $10.66
- HBIO $2.14
- Analyst Decision
- HEQ
- HBIO
- Analyst Count
- HEQ 0
- HBIO 0
- Target Price
- HEQ N/A
- HBIO N/A
- AVG Volume (30 Days)
- HEQ 43.1K
- HBIO 148.4K
- Earning Date
- HEQ 01-01-0001
- HBIO 11-07-2024
- Dividend Yield
- HEQ 9.78%
- HBIO N/A
- EPS Growth
- HEQ N/A
- HBIO N/A
- EPS
- HEQ N/A
- HBIO N/A
- Revenue
- HEQ N/A
- HBIO $97,732,000.00
- Revenue This Year
- HEQ N/A
- HBIO N/A
- Revenue Next Year
- HEQ N/A
- HBIO N/A
- P/E Ratio
- HEQ N/A
- HBIO N/A
- Revenue Growth
- HEQ N/A
- HBIO N/A
- 52 Week Low
- HEQ $9.08
- HBIO $2.12
- 52 Week High
- HEQ $11.84
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- HEQ 39.35
- HBIO 40.90
- Support Level
- HEQ $10.29
- HBIO $2.30
- Resistance Level
- HEQ $10.86
- HBIO $2.61
- Average True Range (ATR)
- HEQ 0.14
- HBIO 0.15
- MACD
- HEQ -0.02
- HBIO -0.02
- Stochastic Oscillator
- HEQ 53.62
- HBIO 2.86
About HEQ John Hancock Hedged Equity & Income Fund of Beneficial Interest
John Hancock Hedged Equity & Income Fund is a closed-end management investment company. Its investment objective is to provide total return with a focus on current income and gains and also consisting of long-term capital appreciation. It invests in various sectors such as financials, consumer discretionary, information technology, energy, healthcare, materials, real estate, consumer staples, short-term investments, and others.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.